Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 14/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 12/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16355316 | 0.95 | MAPK10 (0.42) | MAPK10MAPK9MAPK8ALOX5 | |
| SCHEMBL16355374 | 0.91 | MAPK10 (0.46) | MAPK10MAPK9MAPK8ALOX5CYP17A1 | |
| SCHEMBL19529190 | 0.89 | KDM4E (0.44) | PIK3CAALOX5SRC | |
| SCHEMBL15949831 | 0.89 | CYP11B2 (0.52) | MAPK9MAPK8CHEK1PIK3CACYP17A1 | |
| SCHEMBL30911063 | 0.89 | CYP11B2 (0.52) | MAPK9MAPK8CHEK1PIK3CACYP17A1 | |
| SCHEMBL16355367 | 0.89 | GRM5 (0.41) | MAPK10MAPK9MAPK8PIK3CACYP17A1 | |
| SCHEMBL15959617 | 0.88 | PIK3CA (0.45) | CHEK1PIK3CAROCK2 | |
| SCHEMBL17805222 | 0.87 | CYP11B2 (0.49) | MAPK9MAPK8CHEK1PIK3CACYP17A1 | |
| SCHEMBL17805188 | 0.86 | PIK3CA (0.43) | CHEK1PIK3CA | |
| SCHEMBL17812843 | 0.85 | CYP11B1 (0.44) | PIK3CAALOX5ROCK2CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| EP-3244462-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2017-11-15 | — | — | EP | disclosed |
| EP-3240057-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2017-11-01 | — | — | EP | disclosed |
| WO-2016111254-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2016-07-14 | — | — | WO | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | AHR, SLC18A1, KCNH1 | MAPK10 710/4885MAPK9 679/4885MAPK8 2102/4885 |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, KCNH1 | MAPK10 710/4885MAPK9 679/4885MAPK8 2102/4885 |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, ARNT | MAPK10 714/4885MAPK9 528/4885MAPK8 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.